Jazz Pharmaceuticals plc — Director's Dealing 2015

May 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-05-12

Reporting Person: Gray Peter (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-12	Ordinary Shares	S	697.0	$173.85	Disposed	4953	Direct
2015-05-12	Ordinary Shares	S	7.0	$175.15	Disposed	4946	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.